0 – Page 2 of 3 – Cambridge Enterprise

Cambridge Enterprise licenses Tau protein targeting IP to Cantabio Pharmaceuticals

07 September 2016 • 3 min read

Cambridge Innovation Capital raises £75m via private financing

20 August 2016 • 3 min read

Healthera secures investment from Cambridge Enterprise

17 August 2016 • 2 min read

Battery paste recycling technology developed at Cambridge is licensed to Aurelius Environmental

29 June 2016 • 3 min read

Cambridge spin-out secures £700K to develop smart infrastructure, sensors and Internet of Things

29 June 2016 • 3 min read

Storm Therapeutics secures £12m investment

28 June 2016 • 3 min read

Cambridge University researchers and GSK partner to discover and develop novel HIV therapeutics

17 June 2016 • 3 min read

Cambridge CMOS Sensors acquired by ams

16 June 2016 • 3 min read

Inotec AMD’s advanced wound care technology secures investment from Amadeus

16 May 2016 • 2 min read

Dr Richard Butt appointed CEO of Apollo Therapeutics

14 April 2016 • 3 min read

Cambridge Epigenetix announces $21M financing round led by Google

14 March 2016 • 2 min read

PhoreMost and The Wistar Institute collaborate to identify new druggable targets

10 March 2016 • 2 min read